|
Early View Articles
Value in Health offers readers the opportunity to access complete articles to be published in upcoming issues of Value in Health. These articles are citable by DOI, and by volume and issue.
The online early articles, found at Online Early at: http://www.blackwell-synergy.com/toc/vhe/0/0 are scheduled to appear in the following upcoming issues of Value in Health. The final Table of Contents for each issue will be available when the final issue appears online.
Future Issues:
Value in Health September/October 2008 Volume 11 Issue 5
ECONOMIC EVALUATION
An Economic Evaluation Of Cetuximab Combined With Radiotherapy For Patients With Locally Advanced Head And Neck Cancer In Belgium, France, Italy, Switzerland And The United Kingdom
B. Brown, A. Diamantopoulos, J Bernier, P Schöffski, K Hieke, R Launois, I Griebsch, P Robinson
Cost-Effectiveness of Early Versus Late Cinacalcet Treatment In Addition To Standard Care For Secondary Renal Hyperparathyroidism In The US
Joshua A. Ray, Rohit Borker, Beth Barber, William J. Valentine, Vasily Belozeroff and Andrew J. Palmer
Cost-effectiveness of HIV Screening of Blood Donations in Accra (Ghana)
Marinus van Hulst; Kwamena W.C. Sagoe; Jacobien E. Vermande; Ido P. van der Schaaf, Willem P.A. van der Tuuk Adriani; Kwasi Torpey; Justina Ansah; Julius A.A. Mingle; Cees Th. Smit Sibinga and Maarten J. Postma
Loss-Of-Treatment Response to Infliximab Maintenance Therapy in Crohn’s Disease: A Payor Perspective
Eric Qiong Wu PhD, Parvez M. Mulani PhD, Andrew Peng Yu PhD, Jackson Tang BS, Paul F. Pollack MD
Eonomic Evaluation of Caspofungin versus Liposomal Amphotericin B for Empiric Antifungal Treatment In Patients With Neutropenic Fever IN Italy
Wiro B. Stam PhD, Franco Aversa MD, Ritesh N. Kumar PhD, Jeroen P. Jansen PhD
Cost-Effectiveness of LTBI Treatment for TB Contacts in British Columbia
MCY Tan MA, MSc, CA Marra, PharmD PhD, M. Sadatsafavi MD, MHSc, F. Marra PharmD, O. Morán-Mendoza MD, PhD, S Moadebi, BSc(Pharm), RK Elwood MD, FRCPC, JM FitzGerald MD3, FRCPC
Using Triple Antiplatelet Therapy In Patients With Non ST Elevation Acute Coronary Syndrome Managed Invasively. A Cost-Effectiveness Analysis
Jaime Latour-Pérez MD, PhD, Eva de Miguel Balsa, Lourdes Betegón, Xavier Badia
The Effect of Atrial Fibrillation on Stroke-Related Inpatient Costs in Sweden: A 3-Year Analysis of Registry Incidence Data From 2001
Ola Ghatnekar MSc and Eva-Lotta Glader MD, PhD
Indirect Costs of Rheumatoid Arthritis In Brazil
AB Cordeiro de Azevedo MD, PhD Student, MB Ferraz MD, PhD, RM Ciconelli MD, PhD
Methodological Considerations in Cost Of Prostate Cancer Studies: A Systematic Review
Laurent Molinier MD, Eric Bauvin MD, Christophe Combescure PhD, Christel Castelli PhD, Xavier Rebillard MD, Michel Soulié MD, Jean-Pierre Daurès MD, PhD, Pascale Grosclaude MD, PhD
Optimal Cost-effectiveness Decisions: the Role of the CEAC, CEAF, and EVPI
Garry R. Barton MSc, Andrew H. Briggs DPhil, Elisabeth A.L. Fenwick PhD
Short Note
Economic Evaluation of a Universal Childhood Pneumococcal Conjugate Vaccination Strategy in Ireland
Lesley Tilson BSc (Pharm) PhD, Cara Usher BSc PhD, Karina Butler MB FRCPI, John Fitzsimons MB MRCPI, Fiona O’Hare MB, Suzanne Cotter MB FRCPI FFPHMI, Darina O’Flanagan MB FRCPI FFPHMI, Howard Johnson MB FRCPI FFPHMI, Michael Barry, MD PhD FRCPI
>>To Top
OUTCOMES ASSESSMENT
Further Validation of an Individualized Migraine Treatment Satisfaction Measure (MTSM)
Mona L. Martin RN, MPA, Donald L. Patrick PhD, MSPH, Donald M. Bushnell MA,
Shravanthi R. Gandra PhD, MBA, Kim Gilchrist MD
Development and validation of the “Treatment Satisfaction with Medicines Questionnaire” (SATMED Q)©
Miguel A. Ruiz PhD, Antonio Pardo PhD, Javier Rejas MD, Javier Soto MD, Fernando Villasante MD, José L. Aranguren MD
Self-Reported Adverse Events after Groin Hernia Repair, A Study Based On A National Register
Ulf Fränneby MD, PhD, Gabriel Sandblom MD, PhD, Olof Nyrén MD, PhD, Pär Nordin MD, PhD, Ulf Gunnarsson MD, PhD
Lipid Testing Among Patients Beginning Statin Therapy in General Practice in the United Kingdom
H. Phatak, C. Wentworth, T. A. Burke
How Inducing Covariation in Simulated HDL-C, Triglyceride, and Total Cholesterol Data Affects Framingham Risk Equation Results
Kevin D. Frick, Sonja V. Sorensen, Christopher Hollenbeak
The Estimation Power of Alternative Comorbidity Indices
Onur Baser PhD, Lisa Palmer PhD, Judith Stephenson SM
Bayesian Meta-Analysis of Multiple Treatment Comparisons: An Introduction to Mixed Treatment Comparisons
Jeroen P Jansen PhD, Bruce Crawford MA MPH, Gert Bergman PhD, Wiro Stam PhD
Household Demand For Preventive HIV/AIDS Vaccines In Thailand: Do Husbands’ And Wives’ Preferences Differ?
Dale Whittington, Chutima Suraratdecha , Christine Poulos , Martha Ainsworth , Vimalanand Prabhu , Viroj Tangcharoensathien
Short Note
Quantifying the Decrement in Utility from Perceived Side Effects of Combination Antiretroviral Therapies in Patients With HIV
RS Braithwaite MD, MSc, J Goulet, PhD, I. Kudel PhD, J. Tsevat MD, MPH, AC Justice, MD, PhD
>>To Top
POLICY ANALYSIS
Using Cost-Effectiveness Analysis To Sharpen Formulary Decision Making: The Example Of Tiotropium At The Veterans Affairs Health Care System
Ebere Onukwugha PhD; C. Daniel Mullins PhD; Sylvain DeLisle MD, MBA
Variable Access to Clopidogrel in a Harmonised EU Market
Pieter Stolk PharmD, Svetlana Belitser MSc, Hubert GM Leufkens PhD, Eibert R Heerdink PhD
Parallel Trade of Pharmaceuticals: A Review of Legal, Economic and Political Aspects
TN Bart
>>To Top
Value in Health November/December 2008 Volume 11 Issue 6
ECONOMIC EVALUATION
The Cost-Effectiveness of Atypicals In The UK
Bart Heeg MSc1, Erik Buskens MD, Marc Botteman MSc, Sue Caleo, Mike Ingham, Joep Damen MSc, Frank de Charro, Prof. Ben van Hout
Reductions In Human Papillomavirus-Disease Resource Use And Costs With Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccination: The FUTURE Study Economic Evaluation
Ralph P. Insinga, PhD, Erik J. Dasbach, PhD, Shannon E. Allen, PhD, George W. Carides, PhD, Evan R. Myers, MD, MPH
Cost-Effectiveness Of A Low-Calorie Diet And Orlistat For Obese Persons: Modelling Long Term Health Gains Through Prevention Of Obesity-Related Chronic Diseases
Pieter HM van Baal PhD, Matthijs van den Berg PhD, Rudolf T. Hoogenveen MSc, Sylvia MC Vijgen MSc, Peter M Engelfriet PhD
Economic Valuation of Informal Care: Conjoint Analysis Applied In a Heterogeneous Population of Informal Care-Givers
Bernard van den Berg, PhD, Maiwenn Al, PhD, Job van Exel, MS, Marc Koopmanschap, PhD, Werner Brouwer PhD
Drotrecogin Alfa’s Impact On Intensive Care Workload In Real Life Practice: A Propensity Score Approach
Lionel Riou França MS, Stéphanie Payet MS, Katell Le Lay MS, Robert Launois PhD
Statin Cost-Effectiveness Comparisons Using Real-World Effectiveness Data: Formulary Implications
Robert L. Ohsfeldt PhD, Sanjay K. Gandhi PhD, Kathleen M. Fox PhD, James M. McKenney, PharmD
>>To Top
OUTCOMES ASSESSMENT
Psychometric Equivalence of the OAB-q in Danish, German, Polish, Swedish, and Turkish
Karin S. Coyne PhD, MPH; Mary Kay Margolis MPH, MHA; Chris Thompson BS; Zoe Kopp PhD, MPH
Estimation of Life Expectancy and the Expected Years of Life Lost In Patients with Major Cancers: Extrapolation Of Survival Curves Under High-Censored Rates
Po-Ching Chu, Jung-Der Wang, Jing-Shiang Hwang, Yu-Yin Chang
Willingness to Accept Versus Willingness to Pay In A Discrete Choice Experiment
Janneke PC Grutters MSc, Alfons GH Kessels MD, MSc, Carmen D Dirksen PhD, Debby van Helvoort-Postulart PhD, Lucien JC Anteunis PhD, Manuela A Joore PhD
Sociodemographic and Clinical Correlates of Utility Scores in Alzheimer’s Disease
Edward Alan Miller PhD, MPA, Lon S. Schneider MD, Arthur Zbrozek MSc, MBA, Robert A. Rosenheck MD
Deriving An Algorithm To Convert The 8 Mean SF-36 Dimension Scores Into A Mean EQ-5D Preference-Based Score From Published Studies (Where Patient Level Data Are Not Available)
Roberta Ara MSc; John Brazier PhD
A Predictive Model Of Health State Utilities For HIV Patients In The Modern Era Of Highly-Active Antiretroviral Therapy
Teresa L. Kauf PhD, Neil Roskell MSc, Arran Shearer MSc, Brian Gazzard MD, Josephine Mauskopf PhD, E. Anne Davis PharmD, MS, Christopher Nimsch MS
Health State Utilities In Latent And Active Tuberculosis
Guo N1, Marra CA, Marra F, Moadebi S, Elwood RK, FitzGerald JM
Validity of The EQ-5D Instrument In A Greek General Population
Nick Kontodimopoulos, Evelina Pappa, Dimitris Niakas, John Yfantopoulos, Christina Dimitrakaki, Yannis Tountas
Hispanic Valuation Of The EQ-5D Health States: A Social Value Set For Latin
Americans
Zarate V. MD, MSc, Kind P. MPhil, Chuang LH. MSc
Short Note
Estimating Quality Weights For EQ-5D Health States With The Time Trade-Off Method In South Korea
Min-Woo Jo, MD, PhD, Sung-Cheol Yun, PhD, Sang-Il Lee, MD, PhD, MPH
Short Note
Factors Associated With Variation In Utility Scores Among Patients With Prostate Cancer?
Fumitaka Shimizu MD, Katsuki Fujino, Yoichi M.Ito, Takashi Fukuda PhD, Yoshio Kawachi MD, Shigeru Minowada MD, Makoto Fujime MD, Yasuo Ohashi PhD
"Price Management" And Its Impact On Hospital Pharmaceutical Expenditure And The Availability Of Medicines In New Zealand Hospitals
June M Tordoff MPharm, PhD, MRPharmS, MPS RegPharmNZ; Pauline T Norris, MA(Hons) PhD; David M Reith, FRACP MMedSc PhD
POLICY ANALYSIS
Citizen’s Preferences Regarding Principles to Guide Health Care Allocation Decisions in Thailand
Vijj Kasemsup MD, PhD; Jon C. Schommer PhD; Richard R. Cline PhD; Ronald S. Hadsall PhD
Discrete-Event Simulation Applied To Analysis Of Waiting Lists. Evaluation of A Prioritization System For Cataract Surgery
Mercè Comas MSc; Xavier Castells MD, PhD; Lorena Hoffmeister MSc; Rubén Román MSc; Francesc Cots MSc, PhD; Javier Mar MD, PhD; Santiago Gutiérrez-Moreno MSc; Mireia Espallargues MD, PhD
>>To Top
Value in Health January/February 2009 Volume 12 Issue 1
ECONOMIC EVALUATION
Using Conjoint Analysis To Estimate Healthy-Year Equivalents For Acute Conditions: An Application To Vasomotor Symptoms
F. Reed Johnson, A. Brett Hauber, Semra Özdemir
Budgetary Impact of Varenicline in Smoking Cessation in the UK
Douglas C.A. Taylor MBA, Paula Chu BA, Virginia M. Rosen PhD, Christine L. Baker MPH, David Thompson PhD
Health Valuation Methods and Reference Points: the Case of Tinnitus
Michael Happich, Jörn Moock, Thomas von Lengerke
The Impact Of Proton Pump Inhibitor Compliance On
Health Care Resource Utilization And Costs In Patients With
Gastroesophageal Reflux Disease
Antoine Gosselin MA; Roger Luo PhD; Herve Lohoues PhD, Edmond Toy PhD; Barbara Lewis PhD; Joseph Crawley MS; Mei Sheng Duh MPH, ScD
Long-Term CostT-Effectiveness Of Pioglitazone
Versus Placebo In Addition To Existing Diabetes Treatment: A US Analysis
Based On Proactive
William J. Valentine PhD, Daniel Tucker MD, Andrew J. Palmer MD, Michael E, MinshallMPH, Volker Foos MSc, Cheryl Silberman PhD, MPH on behalf of the PROactive Study Group
The Burden of Migraine in the United States: Current and Emerging Perspectives on Disease Management and Economic Analysis
Elisabeth Hazard PhD; Julie Munakata MS; Marcelo E. Bigal MD, PhD; Marcia FT Rupnow PhD; Richard B. Lipton MD
Mapping the EORTC QLQ C-30 onto the EQ-5D instrument: the potential to estimate QALYs without generic preference data
Lynda McKenzie MSc; Marjon van der Pol PhD
Breaking the silence: Exploring the potential effects of explicit instructions on incorporating income and leisure in TTO exercises
Marieke Krol MSc, Pedram Sendi MD, DSc , Werner Brouwer PhD
The Health Value and Cost of Care for Major Depression
Katherine E. Watkins, M.D., M.S.P.H.; M. Audrey Burnam, Ph.D.; Maria Orlando, Ph.D.; José J. Escarce, M.D., Ph.D; Haiden A. Huskamp, Ph.D.; Howard H. Goldman, M.D., Ph.D.
Cost-effectiveness of treatments reducing coronary heart disease mortality in Ireland, 2000 to 2010
Bennett, Kathleen, PhD; Kabir, Zubair, MD, PhD; Barry, Michael, MD; Tilson, Lesley, PhD; Fidan, Dogan, PhD; Shelley, Emer, MD; Capewell, Simon, MD
Potential for Cost-savings in the Care of Hospitalized Low-risk Community-acquired Pneumonia Patients in China
Zhou Qing-tao, M.D.; He Bei, Bachelor; Zhu Hong, Bachelor
Prevention and Management of Hyperphosphatemia with Sevelamer in Canada: Health and Economic Consequences
Krista F. Huybrechts MS, J. Jaime Caro MDCM, Judith A. O’Brien RN
An Empiric Estimate of the Value of Life: Updating the Renal Dialysis Cost-Effectiveness Standard
Chris P. Lee, PhD; Glenn M. Chertow, MD, MPH; Stefanos A. Zenios, PhD
Gaining Efficiencies: Resources And Demand For Dialysis Around The Globe
Neil, Nancy, PhD; Walker, David; Sesso, Ricardo; Blackburn, Juan; Tschosik, Elizabeth; Sciaraffia, Vito; Garcia-Contreras, Fernando; Capsa, Dimitrie; Bhattacharyya, Samir
The potential clinical and economic outcomes of pharmacogenomic approaches to EGFR-tyrosine kinase inhibitor therapy in non-small cell lung cancer
Josh J. Carlson, PhD; Louis P. Garrison, PhD; Scott D. Ramsey, MD, PhD; David L. Veenstra, PharmD, PhD
Deterministic Sensitivity Analysis for First-order Monte Carlo Simulations: A Technical Note
Geisler BP, MD; Siebert U; Gazelle GS; Cohen DJ; Göhler A
Ultrasound Guided Central Line Placement as Compared to Standard Landmark Technique
Nicholas Young; Stephen Kinsella
>>To Top
OUTCOMES ASSESSMENT
Satisfaction And Adherence In Patients With Iron
Overload Receving Iron Chelation Therapy As Assessed By A Newly
Developed Patient Instrument
Diana Rofail, M.Sc.; Linda Abetz, MA; Muriel Viala, M.Sc; Claire Gait, Mphil; Jean-Francois Baladi, MBA; Krista Payne, M.Ed.
Reliability of the Discrete Choice Experiment at the Input and Output level in Patients with Rheumatoid Arthritis
Ulla Slothuus Skjoldborg PhD, Jørgen Lauridsen PhD, Peter Junker MD
Evaluation Of An Internet-Based Chronic Disease
Trajectory Model For Prostate Cancer Screening
Vibha Bhatnagar MD, MPH, Dominick Frosch PhD, Steven Tally PhD, Charles Hamori MD, Leslie Lenert MD, MS, Robert M. Kaplan PhD
Development and Evaluation of the Adherence to Refills and Medications Scale (ARMS) Among Low-Literacy Patients with Chronic Disease
Sunil Kripalani, MD, MSc; Jessica Risser, MD, MPH; Margaret E. Gatti, MPH; Terry A. Jacobson, MD
Estimating Clinically Meaningful Changes for the Functional Assessment of Cancer Therapy – Prostate: Results from a clinical trial of patients with metastatic hormone-refractory prostate cancer
David Cella, PhD; Michael B. Nichol, PhD; David Eton, PhD; Joel B. Nelson, MD; Parvez Mulani, MA, CPhil
Development of a New Questionnaire to Assess Patient Perceptions of Cancer-Related Fatigue: Item Generation, Item Reduction and Preliminary Validation
Eva Baró BSc; Joan Carulla MD; Javier Cassinello MD; Ramón Colomer MD; Jesús García Mata MD; Pere Gascón MD; Jose Antonio Gasquet MD; Michael Herdman MSc; Cesar Rodríguez MD; Jordi Sánchez MD; Vicente Valentín MD
The Effects of Laparoscopic Surgery and Nosocomial Infections on the Cost of Care: Evidence From Three Common Surgical Procedures
Candace Gunnarsson, Ed.D; John A. Rizzo, Ph.D; Louis Hochheiser, MD
The development of the Herpes Symptom Checklist (HSC) and the Herpes Outbreak Impact Questionnaire (HOIQ)
Lynda C Doward MRes; Stephen P McKenna PhD; David M Meads MSc; Kristijan Kahler RPh, SM; Feride Frech MPH
Estimating a preference-based single index from the Overactive Bladder Questionnaire (OAB_q)
Yaling Yang, MSc; John Brazier, PhD; Aki Tsuchiya, PhD; Karin Coyne, PhD
Validation of Gastrointestinal Quality of Life Index in Swedish for assessing the impact of gallstones on health-related quality of life
Gabriel Sandblom MD, PhD, Per Videhult MD, Britt-Marie Karlson MD, PhD, Staffan Wollert MD, PhD, Mikael Ljungdahl MD, PhD, Bahman Darkahi MD, Haakan Liljeholm MD, Christian Rasmussen MD, PhD
Utility Estimates for Decision-Analytic Modeling in Chronic Heart Failure - Health States Based on NYHA Classes and Number of Rehospitalizations
Alexander Göhler, MD, MSc, MPH; Benjamin P. Geisler, MD; Jennifer M. Manne, BA; Mikhail Kosiborod, MD; Zefeng Zhang, MD, PhD; William S. Weintraub, MD; John A. Spertus, MD, MPH, FACC; Uwe Siebert, MD, MPH, MSc, ScD; David J. Cohen MD, MSc
>>To Top
Value in Health March/April 2009 Volume 12 Issue 2
EDITORIAL
What Ever Happened to FDAMA Section 114? A Look Back After 10 Years
Peter J. Neumann, Sc.D.
FDAMA 1997 - Section 114: Another Look
J. Jackson
>>To Top
ECONOMIC EVALUATION
Cost-Effectiveness of Testing for Breast Cancer Susceptibility Genes
Margaret L. Holland MS; Alissa Huston MD; Katia Noyes PhD MPH
What outcomes are important to patients with long term conditions? A discrete choice experiment
Richardson, Gerry; Bojke, Chris; Kennedy, Anne; Reeves, David; Bower, Peter; Lee, Victoria; Middleton, Elizabeth; Gardner, Caroline; Gately, Claire; Rogers, Anne
Modelling length of stay in hospital and other right skewed data: comparison of phase-type, gamma and log-normal distributions
Malcolm Faddy PhD; Nicholas Graves PhD; Anthony Pettitt PhD
Cost Impact of Diagnostic Imaging for Lower Extremity Peripheral Vascular Occlusive Disease
Joel W Hay, PhD; Elizabeth Lawler; Kent Yucel; Amy Guo; Thomas Balzer; J. Michael Gaziano; Richard E. Scranton
Prescribing trends and drug budget impact of the ARBs in the UK
Betina T. Blak, PhD, MSc, C. Daniel Mullins, PhD, Fadia T. Shaya, PhD, MPH, Linda Simoni-Wastila, BSPharm, PhD, Catherine E. Cooke, PharmD, BCPS, PAHM, Matthew R. Weir, M.D
Value of information and value of implementation: application of a framework to inform resource allocation decisions in metastatic hormone-refractory prostate cancer
Ties Hoomans, MSc, Elisabeth A.L. Fenwick, PhD, Steve Palmer, MSc, Karl Claxton, PhD
Cost-effectiveness of primary versus secondary prophylaxis with pegfilgrastim in women with early-stage breast cancer receiving chemotherapy
Scott D. Ramsey MD, PhD, Zhimei Liu PhD, Rob Boer PhD, Sean D. Sullivan PhD, Jennifer Malin MD, PhD, Quan V. Doan PharmD, Robert W. Dubois MD, PhD, Gary H. Lyman MD, MPH, FRCP (Edin)
What Outcomes Are Important To Patients With Long Term Conditions? A Discrete Choice Experiment
Gerry Richardson, Chris Bojke, Anne Kennedy , David Reeves, Peter Bower, Victoria Lee, Elizabeth Middleton, Caroline Gardner, Claire Gately, Anne Rogers
Information On Centre Characteristics As Costs’ Determinants In Multicentre Clinical Trials: Is Modelling Centre Effect Worth The Effort?
Michele Petrinco, Eva Pagano, Alessandro Desideri, Riccardo Bigi, Marco Ghidina, Alberto Ferrando, Lauro Cortigiani, Franco Merletti, Dario Gregori
The Costs Of Care In Atrial Fibrillation And The Effect Of Treatment Modalities In Germany
Doreen McBride MBA, Anna M. Mattenklotz MSc., Stefan N. Willich MD, MPH, MBA, Bernd Brüggenjürgen MD, MPH
Economic Evaluation of Influenza Pandemic Mitigation Strategies in the US Using a Stochastic Microsimulation Transmission Model
Beate Sander (PhD Candidate), Azhar Nizam, Louis P Garrison Jr, Maarten J Postma, M Elizabeth Halloran, Ira M Longini Jr
Cost-Effectiveness Evaluation Of ERTAPENEM vs PIPERACILLIN/TAZOBACTAM In The Treatment Of Compicated Intra-Abdominal Infections Accounting For Antibiotic Resistance
Jeroen P Jansen PhD, Ritesh Kumar PhD, Yehuda Carmeli MD MPH
A cost-effectiveness model comparing endovascular repair to open surgical repair of abdominal aortic aneurysms in Canada
Gord Blackhouse. MSc, MBA, BCom, Robert Hopkins. BA, BSc, MA ; James M. Bowen, BScPhm, MSc ; Guy De Rose, BSc, MD, FRCSC, FACS ; Teresa Novick, RN, BA ;Jean-Eric Tarride, PhD; Daria O’Reilly, PhD; Feng Xie, PhD; Ron Goeree, MA
The Health and Economic Consequences of Moderate Alcohol Consumption in Germany 2002
Alexander Konnopka; Professor Hans-Helmut König MPH
Excessive Hospitalizations and Its Associated Economic Burden Among People with Diabetes in the United States
Sunny Kim, Ph.D, Kristina S. Boye, Ph.D
Cost analysis of long-term treatment of patients with symptomatic gastroesophageal reflux disease (GERD) with esomeprazole on-demand treatment or esomeprazole continuous treatment. An open, randomised multi-centre study in Switzerland
Professor Thomas Szucs, MD, Christina Thalmann, MSc, Professor Pierre Michetti, MD, Professor Christoph Beglinger, MD
The costs of change: direct medical costs of solid organ transplantation in British Columbia, Canada, 1995-2003
Adrian R. Levy PhD, Boris Sobolev PhD, Douglas James PhD, William Barrable MHSc, Penny Clarke-Richardson MBA, Sean D. Sullivan PhD, Paul A Keown MD DSc FRCPC, Stephen Chung MD FRCSC, Lyn Straatman MD FRCPC, Robert D. Levy MD FRCPC
Comparing the Health Utilities Index Mark 3 (HUI3) with the Short Form-36 Preference-Based SF-6D in Chronic Kidney Disease
Sara N. Davison, MD, MHSc (bioethics), FRCP(C); Gian S. Jhangri, MSc; David H. Feeny, PhD
Cross-cultural validation of the Scales for Outcomes in Parkinson's Disease-Psychosocial Questionnaire (SCOPA-PS) in four Latin American countries
Javier Virués-Ortega, PhD; Francisco Javier Carod-Artal, MD, PhD; Marcos Serrano-Dueñas, MD; Gabriela Ruiz-Galeano, MD; Gloria Meza-Rojas, MD; Carolina Velázquez, MD; Federico Micheli, MD; Pablo Martínez-Martín, MD, PhD
Predicting the SF-6D preference-based index using the eight mean SF-36 health dimension scores: estimating preference-based health related utilities when patient level data are not available
Roberta Ara; John Brazier
Health Utilities in Patients with HIV/AIDS in Thailand
Phantipa Sakthong PhD, Jon C. Schommer PhD, Cynthia R. Gross PhD, Wisit Prasithsirikul MD, Rungpetch Sakulbumrungsil PhD
A Longitudinal Evaluation Of Health-Related Quality Of Life Of Patients With Parkinson’s Disease
Martine Visser PhD, Dagmar Verbaan MSc, Stephanie van Rooden MSc, Johan Marinus PhD, Anne Stiggelbout PhD, Johannes van Hilten MD PhD
Does Attribute Framing In Discrete Choice Experiments Influence Willingness To Pay? Results From A Discrete Choice Experiment In Screening For Colorectal Cancer
Kirsten Howard BSc(Hons I), MAppSc(Biopharm), MPH, MHealthEcon, PhD
Glenn Salkeld BBus, GradDipHealthEcon, MPH, PhD
Mapping utility scores from a disease-specific quality-of-life measure in bariatric surgery patients
Stefan Sauerland MD, MPH, Sylvia Weiner, MD, Karin Dolezalova, MD, Luigi Angrisani, MD,
Carlos Masdevall Noguera, MD, Manuel García-Caballero, MD, Frédéric Rupprecht, MBA, Marc Immenroth, PhD
Mapping the English and Chinese versions of the Functional Assessment of Cancer Therapy–General to the EQ-5D utility index
Yin-Bun Cheung, PhD, Julian Thumboo, FRCP (Edin), Fei Gao, PhD, Gim-Yew Ng, BSc, Grace Pang, MRCP, Wen-Hsin Koo, MRCP, Vijay-Kumar Sethi, FRCR, Joseph Wee, FRCP, Cynthia Goh, PhD
>>To Top
SHORT NOTE Further validation and responsiveness assessment of the Herpes Outbreak Impact Questionnaire (HOIQ) and Herpes Symptom Checklist (HSC)
David M Meads MSc, Stephen P McKenna PhD, Mary-Ann Bonney PhD, Mark T Bloch MD
POLICY ANALYSIS
Who Does the Numbers? The Role of Third Party Technology Assessment to Inform Health Systems’ Decision Making about the Funding of Health Technologies
Marco Barbieri, MSc; Neil Hawkins, PhD; Mark Sculpher, PhD
Economic Evaluation Of The Decisions Of The Israeli Public Committee For Updating The National List Of Health Services In 2006/7
Amir Shmueli PhD
>>To Top
Value in Health Main
Page
|
